We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Joint Venture Proton Therapy Center Under Development

By MedImaging International staff writers
Posted on 27 Feb 2012
A cancer treatment-center project, now under development in the US state of Arizona, is the latest of an ongoing effort to bring cutting-edge treatment technologies to more patients through joint-venture partnerships with physicians and hospitals.

Proton therapy is a groundbreaking cancer treatment that targets tumors with a beam of protons. By delivering doses with pinpoint precision, proton therapy is painless, non-invasive, and very effective in treating tumors while minimizing damage to surrounding healthy tissue.

Accelitech, LLC (Rosemont, IL, USA), a developer and manager of full-cycle management of technology-driven cancer treatment programs, recently announced its inaugural proton therapy project. Due to the high cost and large scope of developing a proton therapy center, there are only a small number of places in the United States where patients can receive the treatment. With recent lower cost options entering the market, Accelitech hopes to change that by using its existing model to target several proton therapy locations over the next two years.

“The technology may be new, but our model for success remains the same,” stated Kerwin Brandt, president and CEO of Accelitech. “Proton therapy is the next generation of cancer treatment, and this project is an exciting opportunity to apply our proven, full-cycle management process to making this state-of-the-art technology available to patients on a broader scale.”

Proton beam therapy is a type of external radiotherapy that targets tumors with beams of protons. It has fewer side effects than standard radiation and is proven to be effective in sensitive areas such as the head, spine, and prostate. Because of the exact localization and unique behavior of protons, higher dosages can be delivered with excellent accuracy, sparing more of the healthy tissue that surrounds the tumor. Proton beam therapy is a noninvasive, pain-free procedure that provides a reduced risk of secondary cancer incidents, making it an appealing alternative for the treatment of growing children.

Related Links:

Accelitech


40/80-Slice CT System
uCT 528
Mammo DR Retrofit Solution
DR Retrofit Mammography
High-Precision QA Tool
DEXA Phantom
Post-Processing Imaging System
DynaCAD Prostate

Channels

Nuclear Medicine

view channel
Image: LHSCRI scientist Dr. Glenn Bauman stands in front of the PET scanner (Photo courtesy of LHSCRI)

New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer

Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.